Fig. 7

Assessment of patient activity. A) shows the follow-up-investigation at day 90 and B) shows the follow-up investigation at day 180. The blue bars represent the dogs treated with pimobendan and the grey bars the dogs treated with placebo. Change in activity could be assessed as stable and more or less active compared to baseline examination